Literature DB >> 30968568

Mortality prediction in systemic lupus erythematosus patients with pulmonary infection.

Zhimin Lu1, Jing Li1, Juan Ji1, Zhifeng Gu1, Zhanyun Da1.   

Abstract

OBJECTIVE: The impact of pulmonary infection (PI) on mortality of patients with systemic lupus erythematosus (SLE) has been established. Nevertheless, the effect of risk factors in mortality remains controversial. The objective of this study is to determine the risk factors of short-term mortality among SLE patients with PI.
METHOD: The clinical data of 54 SLE patients with 59 episodes of PI who were hospitalized from January 2013 to May 2018 was retrospectively analyzed. Demographic data, clinical features, and outcomes were collected. Logistic regression analysis was carried out to determine the independent predictors of 60-day mortality during hospitalization. We used receiver operating characteristics (ROC) curves to verify the indices as mortality predictors in the study patients.
RESULTS: There were a total of 54 patients with 59 episodes of PI. There were 12 deaths during hospitalization. In multivariate analysis, 24-hour urinary protein (24h-PRO) (odds ratio [OR]: 2.713, 95% CI: 1.234-5.965, P = 0.013), peripheral lymphocyte count (OR: 0.066, 95% CI: 0.005-0.887, P = 0.040), and serum complement 3 level (C3) (OR: 0.097, 95% CI: 0.010-0.954, P = 0.045) were associated with mortality among our cohort of SLE patients with PI. ROC curve values were 0.818 for lymphocyte count (95% CI: 0.696-0.907, P = 0.001), 0.894 for 24h-PRO (95% CI: 0.786-0.959, P < 0.001) and 0.825 for C3 (95% CI: 0.704-0.912, P = 0.001). The cut-off value of lymphocytes, 24h-PRO and C3 were 0.53 × 109 /L, 0.92 g and 0.52 g/L, respectively.
CONCLUSION: The presence of albuminuria, lymphopenia and low complement C3 levels were independent prognostic predictors of short-term mortality in SLE patients with PI.
© 2019 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  lupus erythematosus-systemic; mortality; pulmonary infection

Year:  2019        PMID: 30968568     DOI: 10.1111/1756-185X.13555

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  4 in total

1.  Lymphocyte subset clustering analysis in treatment-naive patients with systemic lupus erythematosus.

Authors:  Zhimin Lu; Weiping Li; Yawei Tang; Zhanyun Da; Xia Li
Journal:  Clin Rheumatol       Date:  2020-10-31       Impact factor: 2.980

2.  Autoimmune Diseases and COVID-19 as Risk Factors for Poor Outcomes: Data on 13,940 Hospitalized Patients from the Spanish Nationwide SEMI-COVID-19 Registry.

Authors:  María Del Mar Ayala Gutiérrez; Manuel Rubio-Rivas; Carlos Romero Gómez; Abelardo Montero Sáez; Iván Pérez de Pedro; Narcís Homs; Blanca Ayuso García; Carmen Cuenca Carvajal; Francisco Arnalich Fernández; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Laura Letona Giménez; Carmen Suárez Fernández; Manuel Méndez Bailón; Carlota Tuñón de Almeida; Julio González Moraleja; Mayte de Guzmán García-Monge; Cristina Helguera Amezua; María Del Pilar Fidalgo Montero; Vicente Giner Galvañ; Ricardo Gil Sánchez; Jorge Collado Sáenz; Ramon Boixeda; José Manuel Ramos Rincón; Ricardo Gómez Huelgas
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

3.  Mortality risk prediction in lupus patients complicated with invasive infection in the emergency department: LUPHAS score.

Authors:  Wanlong Wu; Jun Ma; Yuhong Zhou; Chao Tang; Feng Zhao; Fangfang Sun; Wenwen Xu; Jie Chen; Shuang Ye; Yi Chen
Journal:  Ther Adv Musculoskelet Dis       Date:  2019-11-05       Impact factor: 5.346

4.  Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study.

Authors:  Haiting Wang; Yuhong Zhou; Liqin Yu; Wanlong Wu; Liling Zhao; Shikai Geng; Fangfang Sun; Danting Zhang; Nan Shen; Yi Chen; Shuang Ye
Journal:  Lupus Sci Med       Date:  2022-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.